Filana Therapeutics
FLNA
171 hedge funds and large institutions have $504M invested in Filana Therapeutics in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 40 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 52
1.6% less ownership
Funds ownership: 30.42% → 28.82% (-1.6%)
5% less funds holding
Funds holding: 180 → 171 (-9)
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
17% less call options, than puts
Call options by funds: $200M | Put options by funds: $240M
33% less capital invested
Capital invested by funds: $757M → $504M (-$253M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Think Investments
San Francisco,
California
|
+$10.6M |
| 2 |
Morgan Stanley
New York
|
+$10.5M |
| 3 |
BlackRock
New York
|
+$8.24M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$16.8M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
-$13.8M |
| 3 |
SC
Sculptor Capital
New York
|
-$8.7M |
| 4 |
CAC
Cowen and Company
New York
|
-$8.51M |
| 5 |
Millennium Management
New York
|
-$7.25M |
FLNA Hedge Fund Activity: Q4 2021 in Review
171 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2021, worth a combined $504M — down 33% from $757M a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of FLNA and 34 opened new positions — a net loss of 6 holders — while 52 trimmed existing stakes and 57 added.
The largest buyer was Think Investments, opening a new position worth an estimated $10.6M. The largest seller was Group One Trading, cutting an estimated $16.8M.
- 171 institutional investors held Filana Therapeutics (FLNA) as of Q4 2021, down from 180 in Q3 2021.
- Funds reported $504M of Filana Therapeutics stock for Q4 2021, down 33% quarter-over-quarter.
- 34 funds opened new Filana Therapeutics positions in Q4 2021 and 40 closed out, a net change of -6 holders.
- The largest Filana Therapeutics buyer in Q4 2021 was Think Investments, an estimated $10.6M added.
- The largest Filana Therapeutics seller in Q4 2021 was Group One Trading, an estimated $16.8M sold.
Based on aggregated 13F filings for Q4 2021.